HUMA
Humacyte Inc
NASDAQ: HUMA · HEALTHCARE · BIOTECHNOLOGY
$0.84
+2.66% today
Updated 2026-04-30
Market cap
$178.93M
P/E ratio
—
P/S ratio
87.79x
EPS (TTM)
$-0.26
Dividend yield
—
52W range
$1 – $3
Volume
6.7M
Humacyte Inc (HUMA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-0.4%
Last 4 quarters
Revenue YoY growth
-93.5%
Most recent quarter
EPS YoY growth
+10.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-12.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-17.9%
2026-03-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.19 | -46.4% | $0.82 | $0.68 | -17.9% |
| 2025-11-12 | $-0.11 | +31.3% | $1.28 | $1.19 | -7.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.13 | $-0.19 | -46.4% | $467000.00 | -93.5% |
| 2025-09-30 | $-0.16 | $-0.11 | +31.3% | $753000.00 | — |
| 2025-06-30 | $-0.16 | $-0.24 | -50.0% | $301000.00 | — |
| 2025-03-31 | $-0.22 | $-0.08 | +63.5% | $517000.00 | — |
| 2024-12-31 | $-0.26 | $-0.21 | +18.0% | $7.23M | -33.0% |
| 2024-09-30 | $-0.25 | $-0.33 | -32.0% | — | — |
| 2024-06-30 | $-0.24 | $-0.48 | -100.0% | — | — |
| 2024-03-31 | $-0.22 | $-0.29 | -31.8% | — | — |
| 2023-12-31 | $-0.24 | $-0.24 | +0.0% | $10.79M | — |
| 2023-09-30 | $-0.25 | $-0.25 | +0.0% | — | — |
| 2023-06-30 | $-0.22 | $-0.22 | +0.0% | — | — |
| 2023-03-31 | $-0.21 | $-0.36 | -71.4% | — | — |
Frequently asked questions
Has Humacyte Inc beaten earnings estimates?
Humacyte Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -0.4% over the last 4 quarters.
How does HUMA stock react to earnings?
HUMA stock has moved an average of -12.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Humacyte Inc's revenue growth rate?
Humacyte Inc reported year-over-year revenue growth of -93.5% in its most recent quarter, with EPS growing +10.1% year-over-year.